Special Drug Use Investigation for ADOAIR DISKUS COPD (Salmeterol and Fluticasone)

CompletedOBSERVATIONAL
Enrollment

2,000

Participants

Timeline

Start Date

August 31, 2009

Primary Completion Date

April 30, 2012

Study Completion Date

January 31, 2013

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

Salmeterol and Fluticasone

Administered according to the prescribing information in the locally approved label by the authorities.

Trial Locations (1)

296-8602

GSK Investigational Site, Chiba

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY